Company News

Connect with us at BIO International Convention Digital Event 2021!

Kelun-Biotech Will Present an Update on SKB264 at 2021 ESMO

Kelun-Biotech will present an oral update on SKB264 at 2021 ESMO Annual Meeting held from September 16-21.

Image-empty-state.png

September 10, 2021

KLUS Pharma is Attending 2021 BioPharm America Digital Conference

KLUS Pharma will attend 2021 BioPharm America Digital Conference held from September 20-23.

Image-empty-state.png

September 10, 2021

Kelun-Biotech Will Present Updates for A166 at ASCO

Kelun-Biotech will attend and present at ASCO 2021 for A166, an anti-HER2 ADC.

Image-empty-state.png

May 20, 2021

KLUS Pharma is Attending BIO International Convention Digital Event

KLUS Pharma will attend BIO International Convention Digital 2021 from June 14-18.

Image-empty-state.png

May 20, 2021

Kelun-Biotech and Ellipses Pharma Announce a Licensing Agreement for A400

Sichuan Kelun-Biotech Pharmaceutical Co., Ltd. and UK company Ellipses Pharma Ltd. Announce a Licensing Agreement for Innovative Small Molecule Cancer Therapeutics

Image-empty-state.png

March 26, 2021

KLUS Pharma is Attending BIO-Europe Spring

KLUS Pharma will attend BIO-Europe Spring Digital Event held on March 22-25, 2021.

Image-empty-state.png

March 5, 2021

KLUS Pharma is Attending BIO Partnering at JPM

KLUS Pharma will attend BIO Partnering at JPM Digital Event held on January 11-15, 2021.

Image-empty-state.png

December 5, 2020

IND for KL-A289 is Approved in China

The IND for KL-A289, an anti-LAG-3 monoclonal antibody, was recently approved by the NMPA in China.

Image-empty-state.png

September 2, 2020

Looking for Partnerships to Combat COVID-19

We are looking for partnerships to develop and distribute ACV200-17, a peptide drug to prevent COVID-19, in affected countries.

Image-empty-state.png

June 1, 2020

KLUS Pharma to Present at BIO Digital

KLUS Pharma will present an update for SKB264, a novel TROP2 ADC, at BIO Digital Event held on June 8-12, 2020.

Image-empty-state.png

May 7, 2020

KLUS Pharma to Present at ASCO Annual Meeting

KLUS Pharma will present clinical update for our HER2 and TROP2 ADC programs at ASCO held on May 29-31, 2020.

Image-empty-state.png

April 25, 2020